MedPath

Effect of Anti-adhesion Barrier on the Voice Quality After Thyroidectomy.

Not Applicable
Conditions
Thyroid Cancer
Voice Disorders
Thyroid Nodule
Interventions
Device: Anti-adhesion barrier (Collarbarrier)
Registration Number
NCT04853680
Lead Sponsor
Inha University Hospital
Brief Summary

To determine whether the use of anti-adhesion barrier after thyroid surgery can prevent the voice changes after surgery, using objective voice-related indicators.

Detailed Description

* Randomized controlled study

* Including 40 patients in each arm

* Treatment: anti-adhesion barrier apply on the thyroidectomy space

* Control: No use of anti-adhesion barrier

* Primary outcome: VHI-30 (Voice handicap index)

* Secondary outcome: findings from stroboscopy, CSL (Computerize Speech Lab)

* Outcome measurement: preoperative, post-operative 3 months, post-operative 9 months.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients undergoing open thyroidectomy for thyroid cancer
  • Patients whose tumor size is less than 4cm
  • Patients who are not suspected of surrounding organ involvement (T4) or metastasis to central lymph nodes in preoperative imaging
  • Patients with no history of voice-related diseases prior to surgery
  • Patients with normal movement of both vocal cords in the preoperative vocal cord examination
  • Patients who consented to the study and obtained consent for the study
Read More
Exclusion Criteria
  • Patients with uncontrolled high blood pressure, diabetes, chronic renal failure, coagulation disease, etc.
  • History of cardiovascular disease (angina pectoris, heart failure, myocardial infarction, cerebral infarction, cerebral hemorrhage, etc.)
  • Medical history of drug or substance disorder (alcohol, etc.)
  • Patients with diseases related to airways, esophagus, and vocal cords (vocal palsy, vocal cord polyps, etc.)
  • Patients who have already had adhesions in the foreground due to radiation therapy or surgery on the foreground in the past.
  • Patients with a history of keloid or hypertrophic scars
  • Patients planning to perform lateral cervical lymph node dissection
  • Patients with medical thyroid disease, such as Graves' disease and thyroid inflammation in need of treatment
  • Pregnant or lactating female patients
  • Other patients who are in charge of clinical trials as unsuitable for participation in the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TreatmentAnti-adhesion barrier (Collarbarrier)Use of Anti-adhesion barrier on the thyroidectomy space. After the thyroidectomy, anti-adhesion barrier will be applied on the thyroidectomy space, around the trachea, cricothyroid muscle and platysma muscle before the closure of surgical wound.
Primary Outcome Measures
NameTimeMethod
Voice Handicap Index - 30 (VHI-30)Postoperative 9 months

Overall score of VHI (Total 30 points)

Secondary Outcome Measures
NameTimeMethod
GRBAS scorePreoperative 1 day, Post-operative 3 months, Post-operative 9 months.

Grade, Rough, Breathy, Asthenic, Strained score. (0-3 points in each parameter)

Voice range profile (VRP)Preoperative 1 day, Post-operative 3 months, Post-operative 9 months.

Mininum Hz, Maximal Hz

Trial Locations

Locations (1)

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath